Loading…
TCRT
Alaunos Therapeutics, Inc.
NASDAQ· Healthcare· Biotechnology· CUSIP 98973P309
$1.61-3.31%Price as of Aug 29, 18:38 UTC · updated once a day, after the close
Key metrics
- Market cap
- $4.08M
- P/E
- —
- Forward P/E
- —
- P/B
- 3.0x
- Dividend yield
- —
- Payout
- —
- EPS
- -$1.75
- ROE
- -185.95%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- -0.96
- 52-week high
- $4.59
- 52-week low
- $1.55
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -99.5% over 5Y.
today you would have $3.99▼ -99.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 21 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $3.23 | $1.91 | $10.50 | $97.50 | $163.50 | $378.00 | $708.00 | $280.50 | $621.00 | $802.50 | $1,246.50 | $760.50 | $651.00 |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MBIOMustang Bio Inc | $0.54 | — | 0.5x | — | -58.12% | $4.07M |
| RDHLRedHill Biopharma Ltd. | $0.66 | — | 0.8x | — | — | $4.02M |
| REVBRevelation Biosciences Inc | $1.05 | 0.0x | 0.4x | — | -154.77% | $4.18M |
| JAGXJaguar Health, Inc. | $0.81 |
About the company
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
- 1
- Fort Lauderdale, United States
Company description provided by Yahoo Finance.